Antimicrobial Therapeutics Market, By Drug Class (Antibacterials, Antivirals, Antifungals, Antiparasitics), By Route of Administration (Oral, Topical, Injectable, Others), By Disease Indication (Respiratory Infections, Urinary Tract Infections (UTIs), Ski

Antimicrobial Therapeutics Market, By Drug Class (Antibacterials, Antivirals, Antifungals, Antiparasitics), By Route of Administration (Oral, Topical, Injectable, Others), By Disease Indication (Respiratory Infections, Urinary Tract Infections (UTIs), Skin and Soft Tissue infections, Sexually Transmitted Infections (STIs), Gastrointestinal Infections, Central Nervous System Infections and others, Sexually Transmitted Infections (STIs), Gastrointestinal Infections, Central Nervous System Infections, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East)


Antimicrobial therapeutics are medicines that kill or make it harder for bacteria to grow and multiply in people or animals. They are often used to treat serious infections, such as pneumonia or bloodstream infections (BSIs). Antibiotics can be taken by mouth in the form of pills, tablets, or liquids. They can also be injected or given directly into the bloodstream (IV) for more severe infections. They can also be applied to the skin as a cream, spray, or ointment. When used incorrectly, antibiotics can cause serious side effects and lead to resistant microorganisms. This resistance makes it harder to treat infections with the same medicine or even other medicines that are effective against them. Antimicrobial therapeutics are medications used to treat infections caused by microorganisms, including bacteria, viruses, fungi, and parasites. These therapeutics work by either killing the microorganisms or inhibiting their growth. However, the misuse and overuse of these drugs have led to the emergence of antimicrobial resistance, which is a significant global health concern. The global antimicrobial therapeutics market is expected to grow due to the increasing prevalence of infectious diseases, the development of new drugs, and the growing awareness of antimicrobial resistance.

Market Dynamics:

Increasing product approval by regulatory bodies is expected to drive the growth of the market over the forecast period. For instance, Zydus Lifesciences, a pharmaceutical company, announced that it had received final approval from the U.S. Food and Drug Administration (FDA) to market its antifungal medicine Micafungin, which is used to treat certain types of fungal or yeast infections.

Key features of the study:
  • This report provides in-depth analysis of the global antimicrobial therapeutics market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global antimicrobial therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche AG, AstraZeneca plc, Sanofi SA, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc., AbbVie Inc., Allergan plc, Mylan N.V. and Alembic Pharmaceuticals Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global antimicrobial therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antimicrobial therapeutics market
Detailed Segmentation:
  • Global Antimicrobial Therapeutics Market, By Drug Class:
  • Antibacterials
  • Antivirals
  • Antifungals
  • Antiparasitics
  • Global Antimicrobial Therapeutics Market, By Route of Administration:
  • Oral
  • Topical
  • Injectable
  • Others
  • Global Antimicrobial Therapeutics Market, By Disease Indication:
  • Respiratory Infections
  • Urinary Tract Infections (UTIs)
  • Skin and Soft Tissue Infections
  • Sexually Transmitted Infections (STIs)
  • Gastrointestinal Infections
  • Central Nervous System Infections
  • Others
  • Global Antimicrobial Therapeutics Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Antimicrobial Therapeutics Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profile:
  • Pfizer Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • F. Hoffmann-La Roche AG
  • AstraZeneca plc
  • Sanofi SA
  • Bayer AG
  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • AbbVie Inc.
  • Allergan plc
  • Mylan N.V.
  • Alembic Pharmaceuticals Limited


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Antimicrobial Therapeutics, By Drug Class
Market Antimicrobial Therapeutics, By Route of Administration
Market Antimicrobial Therapeutics, By Disease Indication
Market Antimicrobial Therapeutics, By Distribution Channel
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Antimicrobial Therapeutics Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Antimicrobial Therapeutics Market , By Drug Class, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Antibacterials
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Antivirals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Antifungals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Antiparasitics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
6. Antimicrobial Therapeutics Market , By Route of Administration, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019– 2030
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
7. Antimicrobial Therapeutics Market , By Disease Indication, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019– 2030
Segment Trends
Respiratory Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Urinary Tract Infections (UTIs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Skin and Soft Tissue Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Sexually Transmitted Infections (STIs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Gastrointestinal Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Central Nervous System Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
8. Antimicrobial Therapeutics Market , By Distribution Channel, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019– 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
9. Antimicrobial Therapeutics Market , By Region, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2019–2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn )
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn )
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn )
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country,2018 - 2030, (US$ Bn )
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn )
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 - 2030, (US$ Bn )
North Africa
Central Africa
South Africa
10. Competitive Landscape
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson
GlaxoSmithKline plc.
Merck & Co., Inc.
Novartis AG
F. Hoffmann-La Roche AG
AstraZeneca plc.
Sanofi SA
Bayer AG
Bristol Myers Squibb Company
Eli Lilly and Company
Gilead Sciences, Inc.
AbbVie Inc.
Allergan plc
Mylan N.V.
Alembic Pharmaceuticals Limited
Analyst Views
11. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on “Global Antimicrobial Therapeutics Market” - Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings